Signature PrenatalChip®TE
The Signature PrenatalChip®TE (Targeted Enhanced) microarray features a unique clinically-relevant targeted design with densely placed oligo probes in areas of recognized genetic syndromes.
This oligo-based design:
- Detects chromosome imbalances expected to be identified by karyotyping
- Offers enhanced capability to detect and characterize chromosome imbalances that are too small to be identified by karyotyping
Suggested prenatal uses for this microarray include cases with:
- Multiple congenital anomalies
- Ultrasound abnormalities with normal karyotype results
- Advanced maternal age or parental concern
Signature PrenatalChipTE features
- Oligonucleotide-based microarray
- Over 37,000 oligo probes
- Targets over 245 clinically recognized genetic syndromes
- Average backbone coverage of one probe every 100 kb to limit the number of unclear results. (View syndromes tested by the Signature PrenatalChipTE)
- Average of one probe every 10 kb in regions of clinical relevance
Click here to read about the Signature PrenatalChip®OS, another prenatal microarray option.